Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Enping, Hong"'
Autor:
Luis Alejandro Zúñiga, Torben Leßmann, Karan Uppal, Nicola Bisek, Enping Hong, Caroline E. Rasmussen, Jens-Jakob Karlsson, Joachim Zettler, Lars Holten-Andersen, Kathy Bang, Dhruv Thakar, Yu-Chi Lee, Salomon Martinez, Simran Singh Sabharwal, Sebastian Stark, Frank Faltinger, Oliver Kracker, Samuel Weisbrod, Robin Müller, Tobias Voigt, Kornelia Bigott, Mohammad Tabrizifard, Vibeke Miller Breinholt, Amer M. Mirza, David B. Rosen, Kennett Sprogøe, Juha Punnonen
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-17 (2022)
Abstract Background Intratumoral (IT) delivery of toll-like receptor (TLR) agonists has shown encouraging anti-tumor benefit in preclinical and early clinical studies. However, IT delivery of TLR agonists may lead to rapid effusion from the tumor mic
Externí odkaz:
https://doaj.org/article/9c07ff8778c14891ac4c75977cba6fba
Autor:
Anne Månsson Kvarnhammar, Juha Punnonen, Enping Hong, Diana Reich, Karan Uppal, Kathy Bang, David B Rosen, Burkhardt Laufer, Thomas Knappe, Jens Jakob Karlsson, Yu-Chi Lee, Dhruv Thakar, Luis Alejandro Zúñiga, Simran Singh Sabharwal, Janne Damm Olling, Kristian Kjaergaard, Thomas Kurpiers, Meike Schnabel, Philipp Glock, Joachim Zettler, Mathias Krusch, Ana Bernhard, Stefan Heinig, Valentino Konjik, Thomas Wegge, Yvonne Hehn, Steffen Killian, Laura Viet, Josefine Runz, Frank Faltinger, Mohammad Tabrizi, Kristin Laura Abel, Vibeke Miller Breinholt, Stina M Singel, Kennett Sprogøe
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 7 (2022)
Background Recombinant interleukin-2 (IL-2, aldesleukin) is an approved cancer immunotherapy but causes severe toxicities including cytokine storm and vascular leak syndrome (VLS). IL-2 promotes antitumor function of IL-2Rβ/γ+ natural killer (NK) c
Externí odkaz:
https://doaj.org/article/c5975468cd0f4febb405f737118e732f
Autor:
Amer Mirza, David Rosen, Juha Punnonen, Enping Hong, Luis Zuniga, Karan Uppal, Kathy Bang, Simran Sabharwal, Yuchi Lee, Salomon Martinez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ab51cf4acb4a48fda431edd435e3dc09
Autor:
Amer Mirza, David Rosen, Juha Punnonen, Enping Hong, Luis Zuniga, Karan Uppal, Kathy Bang, Simran Sabharwal, Yuchi Lee, Solomon Martinez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/2213c1af161a460dae21110d56f96d23
Autor:
Sivan Elloul, Anne-Sophie Dugast, Shannon McArdel, Enping Hong, Maegan Hoover, Laurence Turka, Zafira Castano, Arjun Reddy Bollampalli, Shannon Leonard, Ryan Pepi, Alex Nanna
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/305ceefb96694077a20dee7fde51ad88
Autor:
Sivan Elloul, Anne-Sophie Dugast, Shannon McArdel, Enping Hong, Arjun Bollampalli, Maegan Hoover, Sneha Pawar, Viral Amin, Kangjian Qiao, Christopher Ta, Laurence Turka, Thomas Wickham
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/8a6fd99397684961baede2a785881b1e
Autor:
Marcela Guzman Ayala, Michelle Hung, Deepika Kaveri, Rebecca Cottman, Elizabeth Leitner, Priscilla Wong, Ronni Ponek, Enping Hong, Manan Shah, Andrew Banicki, Lawrence Naitmazi, Kelly Lee, Wesley Gorman, Russell Gordley, Philip Lee, Timothy Lu
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Enping Hong, Justin R. Halman, Ankit Shah, Edward Cedrone, Nguyen Truong, Kirill A. Afonin, Marina A. Dobrovolskaia
Publikováno v:
Molecules, Vol 24, Iss 21, p 3852 (2019)
The Molecules Editorial Office wishes to make the following erratum to this paper [...]
Externí odkaz:
https://doaj.org/article/003c7a27e4bb492e810ee2e90fe54370
Autor:
Enping Hong, Justin R. Halman, Ankit Shah, Edward Cedrone, Nguyen Truong, Kirill A. Afonin, Marina A. Dobrovolskaia
Publikováno v:
Molecules, Vol 24, Iss 6, p 1094 (2019)
Infusion reactions (IRs) create a translational hurdle for many novel therapeutics, including those utilizing nanotechnology. Nucleic acid nanoparticles (NANPs) are a novel class of therapeutics prepared by rational design of relatively short oligonu
Externí odkaz:
https://doaj.org/article/e9e7229109804a509e320bd4cf4f5eab
Autor:
Alba Gonzalez, Enping Hong, Gozde Yucel, Elizabeth Leitner, Pearley Chinta, Han Deng, Ian Li, Alice Lam, Abla Bakir, Brandon Lee, Papia Chakraborty, Carmina Blanco, Chen-Ting Lee, Niran Almudhfar, Mengxi Tian, Wenqi Song, Andrew Banicki, Otto Contreras, Martin Gieldin, Brian Garrison, Timothy K. Lu, Kanya Rajangam
Publikováno v:
Cancer Research. 83:3195-3195
CD33 and FLT3 are validated targets for myeloid malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). These malignancies have poor prognosis and high clinical unmet need, and current targeted therapies present ample